Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings

Identifieur interne : 000C58 ( Main/Exploration ); précédent : 000C57; suivant : 000C59

Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings

Auteurs : Magda Anastassova Dineva [Royaume-Uni] ; Lourdes Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa. [Royaume-Uni] ; Helen Lee [Royaume-Uni]

Source :

RBID : ISTEX:EE568A42B9A541FB73C5D09C26A9EFFA741CC966

Descripteurs français

English descriptors

Abstract

Currently available nucleic acid testing (NAT)-based assays are complex and time-consuming, and they require expensive instrumentation and dedicated laboratory spaces for sample preparation as well as for amplification and detection of the nucleic acid target. Reagents required for these tests are also expensive and must be transported and stored refrigerated or frozen. These characteristics have limited the use of such assays for point-of-care (POC) testing, especially in resource-poor settings. Efforts to develop simple and rapid NAT-based assays have focused predominantly on the amplification and detection steps, with sample preparation and nucleic acid extraction remaining the bottleneck in the development of NAT systems suitable for POC applications or resource-limited settings. A review of NAT platforms and technologies currently under development and validation for rapid field testing revealed that, in addition to requiring expensive and complex instrumentation, many of these systems also require off-line sample preparation and reagent handling. In their current format, they are therefore not appropriate for POC testing in resource-limited settings. We evaluated several commercially available technologies and procedures for the isolation of nucleic acid with the extraction of HIV-1 RNA from human plasma as a model system. Our results indicate that solid-phase extraction with silica or glass in the presence of a chaotropic salt provides the highest extraction efficiency. However, none of the existing methods and technologies is readily adaptable to a POC system. The integration of sample preparation procedures well suited to NAT-based assays in resource-limited settings therefore remains a challenge.

Url:
DOI: 10.1039/b705672a


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings</title>
<author wicri:is="90%">
<name sortKey="Dineva, Magda Anastassova" sort="Dineva, Magda Anastassova" uniqKey="Dineva M" first="Magda Anastassova" last="Dineva">Magda Anastassova Dineva</name>
</author>
<author wicri:is="90%">
<name sortKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" sort="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" uniqKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa L" first="Lourdes" last="Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.">Lourdes Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.</name>
</author>
<author wicri:is="90%">
<name sortKey="Lee, Helen" sort="Lee, Helen" uniqKey="Lee H" first="Helen" last="Lee">Helen Lee</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:EE568A42B9A541FB73C5D09C26A9EFFA741CC966</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1039/b705672a</idno>
<idno type="url">https://api.istex.fr/document/EE568A42B9A541FB73C5D09C26A9EFFA741CC966/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000619</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000619</idno>
<idno type="wicri:Area/Istex/Curation">000619</idno>
<idno type="wicri:Area/Istex/Checkpoint">000315</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000315</idno>
<idno type="wicri:doubleKey">0003-2654:2007:Dineva M:sample:preparation:a</idno>
<idno type="wicri:Area/Main/Merge">000C88</idno>
<idno type="wicri:Area/Main/Curation">000C58</idno>
<idno type="wicri:Area/Main/Exploration">000C58</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings</title>
<author wicri:is="90%">
<name sortKey="Dineva, Magda Anastassova" sort="Dineva, Magda Anastassova" uniqKey="Dineva M" first="Magda Anastassova" last="Dineva">Magda Anastassova Dineva</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Haematology, University of Cambridge, CB2 2PT, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author wicri:is="90%">
<name sortKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" sort="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" uniqKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa L" first="Lourdes" last="Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.">Lourdes Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Haematology, University of Cambridge, CB2 2PT, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author wicri:is="90%">
<name sortKey="Lee, Helen" sort="Lee, Helen" uniqKey="Lee H" first="Helen" last="Lee">Helen Lee</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Haematology, University of Cambridge, CB2 2PT, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Analyst</title>
<title level="j" type="abbrev">Analyst</title>
<idno type="ISSN">0003-2654</idno>
<idno type="eISSN">1364-5528</idno>
<imprint>
<publisher>The Royal Society of Chemistry.</publisher>
<date type="published" when="2007">2007</date>
<biblScope unit="volume">132</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1193">1193</biblScope>
<biblScope unit="page" to="1199">1199</biblScope>
</imprint>
<idno type="ISSN">0003-2654</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-2654</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acid</term>
<term>Acid testing</term>
<term>Additional reagents</term>
<term>Amplification</term>
<term>Assay</term>
<term>Available technologies</term>
<term>Chaotropic</term>
<term>Chaotropic reagent</term>
<term>Chaotropic salt</term>
<term>Chargeswitch1</term>
<term>Clinical specimens</term>
<term>Complex instrumentation</term>
<term>Detection limit</term>
<term>Detection signals</term>
<term>Detection steps</term>
<term>Electrochemical sensor array</term>
<term>Enigma diagnostics</term>
<term>Enzyme treatment</term>
<term>Expensive instrumentation</term>
<term>Extraction</term>
<term>Extraction efficiency</term>
<term>Extraction procedure</term>
<term>Extraction procedures</term>
<term>Horseradish peroxidase</term>
<term>Human plasma</term>
<term>Infectious disease</term>
<term>Inhibitory substances</term>
<term>Laboratory spaces</term>
<term>Larger sample volumes</term>
<term>Liattm analyzer</term>
<term>Magnetic particles</term>
<term>Microbiol</term>
<term>Microfluidic</term>
<term>Microfuge</term>
<term>Model analyte</term>
<term>Next generation</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleic acid extraction</term>
<term>Oligonucleotide probes</term>
<term>Organic solvents</term>
<term>Other systems</term>
<term>Reagent</term>
<term>Room temperature</term>
<term>Royal society</term>
<term>Salt extraction microfuge</term>
<term>Sample preparation</term>
<term>Sample preparation step</term>
<term>Solidphase extraction</term>
<term>Such assays</term>
<term>Test site</term>
<term>Verigene1</term>
<term>Viral</term>
<term>Viral load</term>
<term>Whole blood</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid</term>
<term>Acid testing</term>
<term>Additional reagents</term>
<term>Amplification</term>
<term>Assay</term>
<term>Available technologies</term>
<term>Chaotropic</term>
<term>Chaotropic reagent</term>
<term>Chaotropic salt</term>
<term>Chargeswitch1</term>
<term>Clinical specimens</term>
<term>Complex instrumentation</term>
<term>Detection limit</term>
<term>Detection signals</term>
<term>Detection steps</term>
<term>Electrochemical sensor array</term>
<term>Enigma diagnostics</term>
<term>Enzyme treatment</term>
<term>Expensive instrumentation</term>
<term>Extraction</term>
<term>Extraction efficiency</term>
<term>Extraction procedure</term>
<term>Extraction procedures</term>
<term>Horseradish peroxidase</term>
<term>Human plasma</term>
<term>Infectious disease</term>
<term>Inhibitory substances</term>
<term>Laboratory spaces</term>
<term>Larger sample volumes</term>
<term>Liattm analyzer</term>
<term>Magnetic particles</term>
<term>Microbiol</term>
<term>Microfluidic</term>
<term>Microfuge</term>
<term>Model analyte</term>
<term>Next generation</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleic acid extraction</term>
<term>Oligonucleotide probes</term>
<term>Organic solvents</term>
<term>Other systems</term>
<term>Reagent</term>
<term>Room temperature</term>
<term>Royal society</term>
<term>Salt extraction microfuge</term>
<term>Sample preparation</term>
<term>Sample preparation step</term>
<term>Solidphase extraction</term>
<term>Such assays</term>
<term>Test site</term>
<term>Verigene1</term>
<term>Viral</term>
<term>Viral load</term>
<term>Whole blood</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Acide</term>
<term>Maladie infectieuse</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Currently available nucleic acid testing (NAT)-based assays are complex and time-consuming, and they require expensive instrumentation and dedicated laboratory spaces for sample preparation as well as for amplification and detection of the nucleic acid target. Reagents required for these tests are also expensive and must be transported and stored refrigerated or frozen. These characteristics have limited the use of such assays for point-of-care (POC) testing, especially in resource-poor settings. Efforts to develop simple and rapid NAT-based assays have focused predominantly on the amplification and detection steps, with sample preparation and nucleic acid extraction remaining the bottleneck in the development of NAT systems suitable for POC applications or resource-limited settings. A review of NAT platforms and technologies currently under development and validation for rapid field testing revealed that, in addition to requiring expensive and complex instrumentation, many of these systems also require off-line sample preparation and reagent handling. In their current format, they are therefore not appropriate for POC testing in resource-limited settings. We evaluated several commercially available technologies and procedures for the isolation of nucleic acid with the extraction of HIV-1 RNA from human plasma as a model system. Our results indicate that solid-phase extraction with silica or glass in the presence of a chaotropic salt provides the highest extraction efficiency. However, none of the existing methods and technologies is readily adaptable to a POC system. The integration of sample preparation procedures well suited to NAT-based assays in resource-limited settings therefore remains a challenge.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Angleterre de l'Est</li>
</region>
<settlement>
<li>Cambridge</li>
</settlement>
<orgName>
<li>Université de Cambridge</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Dineva, Magda Anastassova" sort="Dineva, Magda Anastassova" uniqKey="Dineva M" first="Magda Anastassova" last="Dineva">Magda Anastassova Dineva</name>
</region>
<name sortKey="Lee, Helen" sort="Lee, Helen" uniqKey="Lee H" first="Helen" last="Lee">Helen Lee</name>
<name sortKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" sort="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa, Lourdes" uniqKey="Mahilum Tapaypresent Address Diagnostics For The Real World Ltd Sunnyvale Ca Usa L" first="Lourdes" last="Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.">Lourdes Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa.</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C58 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C58 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:EE568A42B9A541FB73C5D09C26A9EFFA741CC966
   |texte=   Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024